mnexspike - Search News

News

Moderna, COVID-19 and mNexspike

Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it

The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.

Clinical Advisor · 21h

FDA Approves Moderna’s Next-Generation COVID-19 Vaccine mNexspike

Drug Store News · 1d

Moderna obtains FDA OK for mNEXSPIKE COVID-19 vaccine

McKnight's Long-Term Care News4d

New COVID-19 vaccine for older adults gets FDA nod as fresh variant emerges

The World Health Organization has tracked a new COVID-19 variant that has emerged across multiple region. Amid this, the Food ...

3don MSN

RFK Jr. says Moderna agreed to another clinical trial to support new COVID shot

HHS Secretary Robert F. Kennedy Jr. says Moderna (MRNA) has agreed to do another clinical trial to back its newly approved ...

Tokenist5d

Why is Moderna’s Stock Gaining in Premarket Trading Today?

Moderna stock jumped 4.93% to $27.87 in premarket trading after the FDA granted limited approval for mNEXSPIKE, a new COVID-19 vaccine requiring only one-fifth the dose of the company's current ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results